Video Experimental Relacionado
Updated: May 5, 2026
10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
17.1K
Diseño de los inhibidores de las miniproteínas de las adhesinas bacterianas
bioRxiv : the preprint server for biology
|September 2, 2025
Resumen
El diseño de proteínas crea nuevos antimicrobianos al bloquear las adhesinas bacterianas. Estas nuevas terapias tratan y previenen eficazmente las infecciones del tracto urinario sin necesidad de antibióticos.
Área de la Ciencia:
- Ingeniería de proteínas
- Microbiología
- Enfermedades infecciosas
Sus antecedentes:
- Las infecciones bacterianas multirresistentes representan una amenaza significativa para la salud mundial.
- Las adhesinas bacterianas son factores críticos de virulencia que median las interacciones huésped-patógeno e infecciones.
- Las infecciones del tracto urinario (ITU) causadas por bacterias uropatógenas conducen a una morbilidad y mortalidad considerables.
Objetivo del estudio:
- Demostrar que el diseño de proteínas de novo puede generar nuevos antimicrobianos dirigidos a las adhesinas bacterianas.
- Desarrollar miniproteínas de alta afinidad contra las adhesinas específicas de Escherichia coli y Acinetobacter baumannii.
- Evaluar el potencial terapéutico de estos antimicrobianos diseñados para prevenir y tratar las infecciones urinarias.
Principales métodos:
- Diseño de nuevo de miniproteínas de alta afinidad.
- El objetivo de la adhesión FimH es E. las adhesinas coli y Abp1D/Abp2D de A. Baumannii es el nombre de la película.
- Evaluación in vitro e in vivo de la especificidad, estabilidad y eficacia de los antagonistas para interrumpir el reconocimiento bacteriano, bloquear la formación de biopelículas y tratar o prevenir las infecciones urinarias.
Principales resultados:
- Miniproteínas diseñadas con éxito con alta afinidad y especificidad para las adhesinas bacterianas objetivo.
- Se ha demostrado la alteración del reconocimiento de los receptores bacterianos del huésped y la inhibición de la formación de biopelículas.
- Eficacia validada in vivo en el tratamiento y prevención tanto de infecciones urinarias sin complicaciones como de las asociadas con catéteres.
Conclusiones:
- El diseño de proteínas ofrece una estrategia generalizable para desarrollar nuevos antimicrobianos apuntando a los factores de virulencia bacteriana extracelular.
- Los antagonistas de adhesina diseñados representan una clase prometedora de terapias de próxima generación para el tratamiento y la prevención de infecciones bacterianas que evitan los antibióticos.
- Este enfoque produce rápidamente tratamientos efectivos que interrumpen la patogénesis y combaten la resistencia a los antibióticos.
Videos de Conceptos Relacionados
01:30Enzyme Inhibition
72.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.5K
01:29Cytoskeletal Proteins in Bacteria
3.5K
Bacterial cells were initially considered simple, randomly organized structures lacking a cytoskeleton. However, the discovery of cytoskeleton homologs in bacteria led to the change of this opinion. Bacterial cytoskeletal filaments regulate the cell shape, cell polarity, cell division, and partitioning of plasmids during cell division. It was later discovered that bacterial cytoskeletal proteins, mainly actin and tubulin homologs, are diverse compared to their eukaryotic counterparts. On the...
3.5K
01:24Adherens Junctions
5.8K
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types – adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
Adherens Junctions are Dynamic
5.8K
01:23Antimicrobial Proteins
10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
01:23Inhibitors of Gram-positive Cell Wall Synthesis
216
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
01:25Inhibitors of Bacterial Protein Synthesis
127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127